Skip to main content.

Big Pharma

Picture of Emily Bader
Twenty years after Purdue Pharma introduced its pain medication, OxyContin, Maine lawmakers passed a bill that significantly stemmed the flow of pain pills into the state.
Picture of Trudy  Lieberman
There's an urgent need for better media stories that sort through the proposals and give basic descriptions of what the major plans to lower prices would do.
Picture of Gary Schwitzer
Between recent reports of industry-funded research and industry-funded journalism workshops, it feels like a sophisticated campaign by the alcohol industry to sway public opinion is underway, writes HNR's Gary Schwitzer.
Picture of Michael Lujan

As drug prices continue to rise, one in four Americans cannot afford to fill their prescriptions. It's a problem that is growing and warrants a closer look at some of the key drivers and possible solutions.

Picture of Cathryn  Jakobson Ramin

Creating custom hormone therapy is big business for compounding pharmacies. Regulated by state pharmacy boards and not the FDA, compounders have been known to get a pass in the face of substantial trespasses. So just how safe are these drugs?

Picture of William Heisel

When dealing with skeptics of vaccine science, understanding their sacred values of prizing purity and independence can help communicate inoculation's benefits.

Announcements

The nation’s overdose epidemic has entered a devastating new phase. Drugs laced with fentanyl and even more poisonous synthetics have flooded the streets, as the crisis spreads well beyond the rural, largely white communities that initially drew attention. The death rate is escalating twice as fast among Black people than among white people. This webinar will give journalists deep insights, fresh story ideas and practical tips for covering an epidemic that killed more than 107,000 people in the U.S. last year. Sign-up here!

CONNECT WITH THE COMMUNITY

Follow Us

Facebook


Twitter

CHJ Icon
ReportingHealth